|Bid||108.43 x 900|
|Ask||0.00 x 1300|
|Day's range||108.59 - 109.98|
|52-week range||101.24 - 142.60|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||22.76|
|Earnings date||18 Oct 2022 - 24 Oct 2022|
|Forward dividend & yield||1.88 (1.72%)|
|Ex-dividend date||14 July 2022|
|1y target est||127.91|
This week, in legal news Yahoo Finance is following stalled legislation that would have reined in Big Tech; lawsuits piling up against formula maker Abbott; and a simmering legal feud between Twitter and Tesla CEO Elon Musk.
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
Abbott (NYSE: ABT) and WW International, Inc. ("WeightWatchers" or "WW") today announced a strategic partnership that will help people living with diabetes better understand and manage their diabetes and weight. The companies are working together to integrate WeightWatchers' diabetes-tailored weight management program with Abbott's portfolio of FreeStyle Libre® products to create a seamless mobile experience that will give people living with diabetes the information and insights needed to make h